Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C20H25N5O6S |
Molecular Weight | 463.507 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=C(CC[C@@H]2CNC3=C(C2)C(=O)NC(N)=N3)SC(=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O
InChI
InChIKey=QXOPTIPQEVJERB-JQWIXIFHSA-N
InChI=1S/C20H25N5O6S/c1-9-6-14(18(29)23-12(19(30)31)3-5-15(26)27)32-13(9)4-2-10-7-11-16(22-8-10)24-20(21)25-17(11)28/h6,10,12H,2-5,7-8H2,1H3,(H,23,29)(H,26,27)(H,30,31)(H4,21,22,24,25,28)/t10-,12-/m0/s1
Molecular Formula | C20H25N5O6S |
Molecular Weight | 463.507 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Pelitrexol (also known as AG2037) was developed by Pfizer as a glycinamide ribonucleotide formyltransferase inhibitor. This drug was studied in phase II clinical trials in patients with metastatic non-small cell lung cancer and in patients with metastatic colorectal cancer who failed treatment. In addition, the drug participated in a phase I clinical trial in treating patients who have advanced, metastatic, or recurrent solid tumors. Information about the further development of pelitrexol is not available.
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 16:14:32 GMT 2023
by
admin
on
Sat Dec 16 16:14:32 GMT 2023
|
Record UNII |
DHT6E8M4KP
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C1556
Created by
admin on Sat Dec 16 16:14:32 GMT 2023 , Edited by admin on Sat Dec 16 16:14:32 GMT 2023
|
||
|
NCI_THESAURUS |
C2692
Created by
admin on Sat Dec 16 16:14:32 GMT 2023 , Edited by admin on Sat Dec 16 16:14:32 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID50196245
Created by
admin on Sat Dec 16 16:14:32 GMT 2023 , Edited by admin on Sat Dec 16 16:14:32 GMT 2023
|
PRIMARY | |||
|
CHEMBL2107361
Created by
admin on Sat Dec 16 16:14:32 GMT 2023 , Edited by admin on Sat Dec 16 16:14:32 GMT 2023
|
PRIMARY | |||
|
C516135
Created by
admin on Sat Dec 16 16:14:32 GMT 2023 , Edited by admin on Sat Dec 16 16:14:32 GMT 2023
|
PRIMARY | |||
|
135431074
Created by
admin on Sat Dec 16 16:14:32 GMT 2023 , Edited by admin on Sat Dec 16 16:14:32 GMT 2023
|
PRIMARY | |||
|
446022-33-9
Created by
admin on Sat Dec 16 16:14:32 GMT 2023 , Edited by admin on Sat Dec 16 16:14:32 GMT 2023
|
PRIMARY | |||
|
300000034319
Created by
admin on Sat Dec 16 16:14:32 GMT 2023 , Edited by admin on Sat Dec 16 16:14:32 GMT 2023
|
PRIMARY | |||
|
C2633
Created by
admin on Sat Dec 16 16:14:32 GMT 2023 , Edited by admin on Sat Dec 16 16:14:32 GMT 2023
|
PRIMARY | |||
|
DB12757
Created by
admin on Sat Dec 16 16:14:32 GMT 2023 , Edited by admin on Sat Dec 16 16:14:32 GMT 2023
|
PRIMARY | |||
|
DHT6E8M4KP
Created by
admin on Sat Dec 16 16:14:32 GMT 2023 , Edited by admin on Sat Dec 16 16:14:32 GMT 2023
|
PRIMARY | |||
|
8362
Created by
admin on Sat Dec 16 16:14:32 GMT 2023 , Edited by admin on Sat Dec 16 16:14:32 GMT 2023
|
PRIMARY | |||
|
OO-35
Created by
admin on Sat Dec 16 16:14:32 GMT 2023 , Edited by admin on Sat Dec 16 16:14:32 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |